Synaptic Structure and Transcriptomic Profiling of Reward and Sensory Brain Areas in Male Mice of Fentanyl Addiction

Overview

Journal Subst Abuse Rehabil

Publisher Dove Medical Press

Specialty Psychiatry

Date 2024 Dec 11

PMID 39659661

Authors

Junli Feng

Ningsi Xu

Linhua Wang

Haixing Wang

Yi Zhou

Qing Shen

Affiliations

Soon will be listed here.

Abstract

Background: Opioid-based medications are powerful analgesics commonly prescribed for pain management, but they are also highly addictive. The over-prescription of opioids analgesics has triggered current opioid crisis, which now has expanded to heroin and illicit synthetic opioids like fentanyl and its analogues. The side effects of fentanyl abuse have been well recognized, yet the underlying molecular adaptations across brain regions upon fentanyl exposure remain elusive.

Methods: The transmission electron microscopy (TEM) and next-generation RNA-sequencing (RNA-seq) were used to investigate the ultrastructure synaptic alterations and transcriptional profiling changes of reward and sensory brain regions in mice after fentanyl exposure.

Results: The naloxone-precipitated acute withdrawal symptoms were observed in mice exposed to fentanyl. Results of TEM showed an increase in the number of synapses, widening of synaptic gaps, and thickening of postsynaptic density in the NAc of the fentanyl addiction mice, accompanied by obvious mitochondrial swelling. RNA-seq identified differentially expressed genes (DEGs) in prefrontal cortex of mice brains after fentanyl exposure, and the expression of some addiction-related genes such as and showed the most striking changes among experimental groups. KEGG enrichment analysis indicated that these DEGs were related to the development of addiction behavior, dopaminergic/GABAergic/serotonergic synapse, synapse assembly/synaptic plasticity/synaptic vesicle cycle, cAMP/MAPK signaling pathway, neuroactive ligand-receptor interactions. These transcriptomic changes may be correlated with the structural and behavioral changes observed in fentanyl-exposed mice.

Discussion: The findings of this study contribute to a better understanding of the molecular mechanism of addiction behavior, which is essential for the development of optimized therapy strategies for addicts.

References

Di Ciano P, Grandy D, Le Foll B . Dopamine D4 receptors in psychostimulant addiction. Adv Pharmacol. 2014; 69:301-21. PMC: 4410854. DOI: 10.1016/B978-0-12-420118-7.00008-1. View

Trucco E, Hicks B, Villafuerte S, Nigg J, Burmeister M, Zucker R . Temperament and externalizing behavior as mediators of genetic risk on adolescent substance use. J Abnorm Psychol. 2016; 125(4):565-75. PMC: 4850114. DOI: 10.1037/abn0000143. View

Wachman E, Hayes M, Lester B, Terrin N, Brown M, Nielsen D . Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. J Pediatr. 2014; 165(3):472-8. PMC: 4145036. DOI: 10.1016/j.jpeds.2014.05.040. View

Ikemoto S . Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev. 2007; 56(1):27-78. PMC: 2134972. DOI: 10.1016/j.brainresrev.2007.05.004. View

Li J, Szkudlarek H, Renard J, Hudson R, Rushlow W, Laviolette S . Fear Memory Recall Potentiates Opiate Reward Sensitivity through Dissociable Dopamine D1 versus D4 Receptor-Dependent Memory Mechanisms in the Prefrontal Cortex. J Neurosci. 2018; 38(19):4543-4555. PMC: 6705931. DOI: 10.1523/JNEUROSCI.3113-17.2018. View

Botticelli L, Micioni Di Bonaventura E, Del Bello F, Giorgioni G, Piergentili A, Romano A . Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors. Nutrients. 2020; 12(8). PMC: 7468707. DOI: 10.3390/nu12082288. View

Listos J, Listos P, Baranowska-Bosiacka I, Karpiuk A, Filarowska J, Lupina M . Linagliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor, Reduces Physical and Behavioral Effects of Morphine Withdrawal. Molecules. 2022; 27(8). PMC: 9028142. DOI: 10.3390/molecules27082478. View

Olusakin J, Kumar G, Basu M, Calarco C, Fox M, Alipio J . Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile mice. Neuropsychopharmacology. 2023; 48(12):1724-1734. PMC: 10579237. DOI: 10.1038/s41386-023-01639-8. View

Todd D, Clapp M, Dains P, Karacay B, Bonthius D . Purkinje cell-specific deletion of CREB worsens alcohol-induced cerebellar neuronal losses and motor deficits. Alcohol. 2022; 101:27-35. PMC: 9783827. DOI: 10.1016/j.alcohol.2022.02.005. View

10.

Sun N, Yu L, Gao Y, Ma L, Ren J, Liu Y . MeCP2 Epigenetic Silencing of Gene in Primary Sensory Neurons Under Neuropathic Pain Conditions. Front Neurosci. 2021; 15:743207. PMC: 8602696. DOI: 10.3389/fnins.2021.743207. View

11.

Burns J, Kroll D, Feldman D, Kure Liu C, Manza P, Wiers C . Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders. Front Psychiatry. 2019; 10:626. PMC: 6759955. DOI: 10.3389/fpsyt.2019.00626. View

12.

Zhang H, Kranzler H, Yang B, Luo X, Gelernter J . The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry. 2007; 13(5):531-43. PMC: 3163084. DOI: 10.1038/sj.mp.4002035. View

13.

Hu Y, Fang Z, Yang Y, Rohlsen-Neal D, Cheng F, Wang J . Analyzing the genes related to nicotine addiction or schizophrenia via a pathway and network based approach. Sci Rep. 2018; 8(1):2894. PMC: 5811491. DOI: 10.1038/s41598-018-21297-x. View

14.

Bingor A, Azriel M, Amiad L, Yaka R . Potentiated Response of ERK/MAPK Signaling is Associated with Prolonged Withdrawal from Cocaine Behavioral Sensitization. J Mol Neurosci. 2021; 71(11):2229-2236. PMC: 8585797. DOI: 10.1007/s12031-021-01799-6. View

15.

Rivera A, Suarez-Boomgaard D, Miguelez C, Valderrama-Carvajal A, Baufreton J, Shumilov K . Dopamine D Receptor Is a Regulator of Morphine-Induced Plasticity in the Rat Dorsal Striatum. Cells. 2022; 11(1). PMC: 8750869. DOI: 10.3390/cells11010031. View

16.

Fletcher P, Grottick A, Higgins G . Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology. 2002; 27(4):576-86. DOI: 10.1016/S0893-133X(02)00342-1. View

17.

Meaden C, Mozeika A, Asri R, Santos C . A review of the existing literature on buprenorphine pharmacogenomics. Pharmacogenomics J. 2020; 21(2):128-139. DOI: 10.1038/s41397-020-00198-1. View

18.

Heidari M, Amini A, Bahrami Z, Shahriari A, Movafag A, Heidari R . Effect of Chronic Morphine Consumption on Synaptic Plasticity of Rat's Hippocampus: A Transmission Electron Microscopy Study. Neurol Res Int. 2014; 2013:290414. PMC: 3863539. DOI: 10.1155/2013/290414. View

19.

Lohoff F, Dahl J, Ferraro T, Arnold S, Gallinat J, Sander T . Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder. Neuropsychopharmacology. 2006; 31(12):2739-47. PMC: 2507868. DOI: 10.1038/sj.npp.1301196. View

20.

Fattore L, Diana M . Drug addiction: An affective-cognitive disorder in need of a cure. Neurosci Biobehav Rev. 2016; 65:341-61. DOI: 10.1016/j.neubiorev.2016.04.006. View